-
Johnson & Johnson Launches The 3rd Opinion to Empower Lung Cancer Patients Across Asia Pacific
August 1, 2025Marking World Lung Cancer Day, Johnson & Johnson has unveiled The 3rd Opinion, a groundbreaking initiative...
-
Zydus Receives Tentative USFDA Approval for Ibrutinib Tablets in Multiple Strengths, Targeting $2.1 Billion Market
July 24, 2025Zydus Lifesciences Ltd., one of India’s leading pharmaceutical companies, announced today that it has received tentative...
-
Akums Unveils Ripasudil-Timolol Combination for Glaucoma and Ocular Hypertension
April 4, 2025In a major breakthrough for ophthalmic care, Akums Drugs & Pharmaceuticals Ltd., India’s leading contract development...
